- Home
- ELTX vs AVX Comparison
ELTX vs AVX Comparison
Compare ELTX & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELTX | AVX |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 119.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELTX | AVX |
|---|---|---|
| Price | $11.79 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 138.3K | ★ 756.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,301,000.00 | N/A |
| Revenue This Year | N/A | $530,767.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.60 | $0.55 |
| 52 Week High | $14.93 | $2.27 |
Technical Indicators
Market Signals| Indicator | ELTX | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 46.43 |
| Support Level | $7.78 | $0.55 |
| Resistance Level | $12.52 | $2.26 |
| Average True Range (ATR) | 1.12 | 0.08 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 51.27 | 83.24 |
Price Performance
Historical ComparisonAbout ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.